Isracann Biosciences Inc.  (CSE: IPOT) (FRA: A2PT0E) (OTC: ISCNF) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, is pleased to announce that the Financial Industry Regulatory Authority, Inc. has approved the Company’s request to change its OTC ticker symbol to ISCNF, effective as of the opening of market trading on November 15, 2019.

The previous trading symbol was ATLED and has been changed to more accurately represent our corporate brand and primary operations in the cannabis sector. The Company is also pleased to announce that it has secured DTC eligibility by The Depository Trust Company (“DTC”) for electronic settlement and transfer of its common shares in the United States.

“Trading under the new OTC ticker symbol ISCNF and achieving DTC eligibility is a major step forward in making it materially easier for US-based investors who are intrigued by the idea of buying shares in an Israeli cannabis venture operated by sector experienced entrepreneurs and capital markets professionals. Our strategic aim is straightforward and leverages the national brand excellence of the Israeli agricultural industry combined with planned industrial scale production of low cost premium quality cannabis targeting export into the massive European marketplace. It’s a uniquely scalable venture that combines numerous positive attributes including a team that knows how to execute,” stated Darryl Jones, Company CEO. “This is an important step in propelling our story to wider audiences and to materially grow our investor base.”

No action is required to be taken by current shareholders with relation to the trading symbol change, and no changes have been made to the Company’s share capital, management, or control. Isracann’s shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol CSE: IPOT, as well as the Frankfurt Stock Exchange under the symbol FRA: A2PT0E.

Updates relating to the additional corporate changes mentioned above will be announced as initiatives continue to progress.

ON BEHALF OF THE BOARD OF DIRECTORS

“Darryl Jones”

Darryl Jones
Chief Executive Officer and President

About OTC Markets Group Inc.
OTC Markets Group Inc. operates the OTCQX Best Market, the OTCQB Venture Market, and the Pink Open Market for 10,000 U.S. and global securities. Through OTC Link ATS and OTC Link ECN, the OTC Markets Group connects a diverse network of broker-dealers that provide liquidity and execution services. OTC Markets Group enables investors to easily trade through the broker of their choice and empowers companies to improve the quality of information available for investors.

About the Depository Trust Company
The Depository Trust Company (“DTC”), a subsidiary of the Depository Trust & Clearing Corporation (“DTCC”) and manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered “DTC eligible.” This reduces costs and accelerates the settlement process for investors and brokers, allowing the stock to be traded over a much wider selection of brokerage firms by coming into compliance with their requirements.

About Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (OTC: ISCNF)
Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel’s agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. The Company has secured agreements within Israel for medicinal marijuana cultivation. For more information visit: www.isracann.com.

The CSE does not accept responsibility for the adequacy or accuracy of this release.
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission, and the Alberta Securities Commission.

Contact
Investor Relations
Toll Free: +1 855.205.0226
Email: inquiries@isracann.com
Web:  www.isracann.com

News by QuoteMedia
www.quotemedia.com

Chemesis International Inc. (CSE:CSI) (OTC:CADMF), announces the filing of its audited fiscal 2019 year-end consolidated financial statements and reports on the most recently completed periods.

2019 HIGHLIGHTS

• The Company reported combined revenues of CAD $7.5M for Q4 and Q3 of fiscal 2019 respectively, with combined gross profit of CAD $1.4M for those two periods.

• The Company commercialized its California based extraction facility in January 2019 and began to extract THC distillate for finished goods, for sale throughout the state.

• The Company closed the acquisition of Colombia based, La Finca Interacviva-Arachna Med, a licensed cultivator, producer, distributor, and seller of cannabis products with export abilities into global markets.

• The Company closed the definitive agreement to acquire an additional extraction and manufacturing facility in Cathedral City, California. The fully licensed facility further allowed the Company to expand its ability to extract THC, CBD and other cannabinoid and terpene products.

• The Company closed the acquisition of Puerto Rico based, Natural Ventures PR, a licensed medical cultivator, manufacturer and distributor of high-quality cannabis products.

SUBSEQUENT EVENTS

• The Company announced the closing of CAD $2M in equity financings.

• Chemesis completed the acquisition of a controlling interest in GSRX Industries Inc. (“GSRX”), a leader in retail cannabis dispensaries, distribution & brand development. Through this acquisition, Chemesis further expands its operations into the retail dispensary markets in California and Puerto Rico. This allows the Company to increase profitability of its existing manufacturing and cultivation products through sales directly to consumers. GSRX’s financial statements will be consolidated under Chemesis International from August 29, 2019 onwards. The consolidated financial statements for the year ended June 30, 2019, do not include GSRX’s operations.

• Chemesis announced a partnership with Happy Tea and secured a $4M USD purchase order Happy Tea’s CBD product catalogue. The Company will distribute Happy Tea products throughout Puerto Rico and the United States.

Edgar Montero, CEO of Chemesis stated, “the Company’s operations continue to see increases in revenue quarter over quarter and we anticipate our operations will continue to grow as we see significant demand for the products we manufacture and package. The Company’s revenues, accounts receivables and inventory are growing consistently. Chemesis is also putting forth further resources to expand into additional US States to expand the Company’s multi-state operations. The team has created a foundation that we believe will create significant opportunities in 2020.”

Chemesis remains in a stable financial position with access to CAD $32.6M in drawdown equity facilities.

The audited condensed consolidated financial Statements and MD&A for the year ended June 30, 2019 will be filed on SEDAR and available at www.sedar.com.

On Behalf of The Board of Directors
Edgar Montero
CEO and Director

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia.

The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.

Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.

Investor Relations:

ir@chemesis.com

1 (604) 398-3378

Social Media:

Chemesis.facebook

Chemesis.twitter

Chemesis.instagram

DesertZen.instagram

CaliforniaSap.instagram

Jay&SB.instagram

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including finalizing an acquisition in Colombia. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Chemesis International Inc.

View source version on accesswire.com:
https://www.accesswire.com/565339/Chemesis-International-Inc-Reports-2019-Year-End-Audited-Financial-Statements

News by QuoteMedia
www.quotemedia.com

Media Relations, Caitlin O’Hara, Caitlin.Ohara@canopygrowth.com, 613-291-3239; Vice President, Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext. 122Copyright CNW Group 2019

News by QuoteMedia
www.quotemedia.com

Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNHF), a leading vertically-integrated Nevada based cannabis company, announced today that it has been granted final permits to begin production at its 15,000 square foot customer-facing production facility co-located at the Planet 13 Cannabis Entertainment Complex.

“Since we opened the SuperStore and began serving approximately 2,000 customers per day, we haven’t been able to keep our inhouse brands in stock. Our new production facility will increase our production capacity by over ten times and help us to meet the demand. Currently, about 15% of SuperStore sales are Planet 13’s in-house brands, we expect with the increase in production capacity to be able to capture a much larger share of SuperStore sales and expand into the wholesale market,” said Bob Groesbeck, Co-CEO of Planet 13.

The Production Facility offers an immersive experience to customers, featuring 115 feet of windows where visitors can watch and learn what goes into the creation of individual products.  Interactive kiosks are available near the production viewing area to teach customers what goes into making their favourite product, offering Planet 13 a powerful branding opportunity.

The highly automated Production Facility utilizes robotics to lower costs and is capable of processing 600 lbs of plant biomass per day at full production, a throughput increase of approximately 1,300% from Planet 13’s current production facility. The expansion allows Planet 13 to increase the production of its existing TRENDI and Leaf & Vine vape and concentrate lines and begin production of its two new edible lines, HaHa Gummies and Dreamland Chocolates along with its beverage line, Elysium.

About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas – the entertainment capital of the world. Planet 13’s mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13’s shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, future expansion plans.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MMDC. Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s annual information form dated April 30, 2019 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Planet 13 Holdings Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2019/01/c0342.html

Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a leading online platform for cannabis products, accessories, and responsible education, is pleased to announce the appointment of Mr. Baran Dilaver to its board of directors and Ms. Annie Holmes as chief financial officer. Ms. Holmes succeeds Ken Ngo who will be leaving Namaste to pursue another opportunity.

“I would like to welcome both Mr. Dilaver and Ms. Holmes to the Namaste team as they bring extensive experience and capabilities as we move the Company into the next stage of growth,” said Meni Morim, CEO of Namaste Technologies. “The addition of Baran and Annie, two outstanding individuals with significant experience in cannabis, consumer packaged goods and financial strategies, will help drive the Company forward.”

Mr. Baran Dilaver is an entrepreneur, creator, and accomplished executive. He has served as CEO and COO at public and private companies, launched over a dozen well-known brands worldwide, and has developed many award-winning products for prominent institutions. His previous venture, Firefly Vapor, where he served as the COO and CMO, was recently sold to a larger company and the ensuing company went public in early 2019. Baran recently helped facilitate one of the largest Series A capital raises in cannabis, $35M for Mile High Labs, and co-founded FutureScape, a technology focused product design and branding firm, and AccessX, a boutique venture capital firm, focused on biotech and cannabis. Mr. Dilaver has an extensive background in cannabis and consumer packaged goods and is a frequent speaker at industry conferences. He studied Economics at the University of California, Berkeley, where he excelled in academics and athletics earning scholarships in both fields.

Ms. Annie Holmes is a strategic thinker with over 15 years of senior executive experience leading corporations through complex restructurings, international expansion and large capital transactions. As Principal of Chartered Course, she provided strategic and financial advice to public and private clients in both the domestic and international markets. She has held the position of chief financial officer for a number of private companies and senior financial roles with publicly traded Smart Employee Benefits Inc. and Katanga Mining Inc. Ms. Holmes received her ICD.D designation from the Rotman School of Management, holds a Bachelor of Arts Honours from the University of Toronto, and earned her Chartered Accountant designation with Grant Thornton.

In accordance with the terms of the consulting agreement between Namaste and Ms. Holmes providing for the provision of services as chief financial officer of the Company, Ms. Holmes is entitled to participate in the Company’s stock option plan. Subject to approval by the board of directors of the Company, Ms. Holmes will be granted stock options in connection with the commencement of her engagement. A subsequent news release disclosing the number of stock options to be granted to Ms. Holmes and the terms of such stock options will be disseminated upon approval by the board of directors.

Namaste also announces that Kenneth Jones has resigned from the Company’s board of directors. The Company would like to thank Mr. Jones and Mr. Ngo for their service and dedication and wish them well in their future endeavors.

About Namaste Technologies Inc.
With headquarters in Toronto, ON, and offices in both B.C. and around the globe, Namaste Technologies is the world’s leading online platform for cannabis products, accessories, and responsible education. The company’s ‘everything cannabis store’, CannMart.com, provides customers with a diverse selection of hand-picked products from a multitude of federally-licensed cultivators, all on one convenient site. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions. For further information about Namaste, please visit NamasteTechnologies.com

Information on the Company and its many products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
Cannmart.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including management’s perceptions of Namaste’s standing in the online marketplace for cannabis products, future growth, the proposed grant of incentive stock options to Annie Holmes in connection with her engagement as chief financial officer of the Company, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom, risks specifically related to the Company’s international operations, and risks relating to the market price of the Common Shares. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/namaste-technologies-announces-changes-to-management-and-board-of-directors-300949835.html

SOURCE Namaste Technologies Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2019/01/c1243.html

Vapen MJ (OTCQX:VAPNF; CSE: VAPN) (“Vapen MJ”) a fully integrated manufacturer and distributor of cannabis THC and hemp CBD products under the Vapen Brand, leveraging core expertise in extraction, outdoor cultivation and marketing to build wholesale distribution through revenue and profit sharing partnerships, announced today a cannabis THC production, extraction and cultivation partnership with the principals and founders of Texoma House of Cannabis to form Vapen Oklahoma, LLC in Oklahoma .

Texoma House of Cannabis has a licensed retail dispensary, as well as Texoma Cultivation greenhouse and outdoor growing operations in Madill, OK. Oklahoma is one of the fastest growing medical marijuana markets in the U.S. according to the August 2019 Annual Marijuana Business Factbook report, based on the average number of patients as a percentage of the population.

The new, state-of-the-art extraction and production facility is anticipated to be fully operational and selling product wholesale to licensed Oklahoma dispensaries throughout the state by the end of 2019. Vapen MJ will provide the Vapen brand, standard operating procedures (SOPs), and back office support for the partnership. The partnership with Texoma will facilitate the launch of Vapen branded product including a line of THC concentrates, edibles and extraction products to dispensaries in the state of Oklahoma .

“We are strategically adding capacity in a new market that has one of the fastest-growing medical marijuana patient populations. We will be launching Vapen branded, safe products that deliver our high quality and purity standards,” commented Thai Nguyen , Founder and Chief Executive Officer of Vapen MJ. “Our partner, with a retail presence and outdoor growing capability in the state of Oklahoma as well as greenhouse operations, has built a solid reputation for quality cannabis products. This relationship underscores our commitment to expanding through partnerships in new markets as we execute our growth strategy to expand our U.S. presence and increase our brand awareness.”

For more information please visit our websites at www.vapenmj.com or www.vapencbd.com.

About Texoma House of Cannabis

Texoma House of Cannabis is a state-licensed marijuana dispensary in Southern Oklahoma that stemmed from a desire to supply top-quality hemp-derived alternative medicine to the people who need it in the Sooner State. We aim to become the go-to resource for anything related to medical marijuana — from serving as an educational resource on the latest rules and regulations and how to apply for a medical marijuana patient license to helping customers determine and purchase the best products and accessories to manage their symptom relief. THC Texoma is a proud member of the National Cannabis Industry Association.  www.THCtexoma.com

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand.  Vapen MJ expansion plans include partnering with cannabis license holders and hemp farms in multiple states within the US.

We seek Safe Harbour.

More

View original content:http://www.prnewswire.com/news-releases/vapen-mj-announces-cannabis-thc-extraction-production-and-cultivation-partnership-in-oklahoma-300946725.html

SOURCE Vapen MJ Ventures Corporation

Share

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Vapen MJ (OTCQX:VAPNF; CSE:VAPN) (“Vapen MJ”) a fully integrated manufacturer and distributor of cannabis THC and hemp CBD products under the Vapen Brand, leveraging core expertise in extraction and marketing to build wholesale distribution through revenue and profit sharing partnerships, announced today that Bob Brilon, President and CFO will be presenting at the following conferences in October.

The Microcap Rodeo

• Presentation date and time: Tuesday, October 15 at 3:50 pm CT with management hosting one-on-one meetings the same day
• Location: Hilton Austin, Austin, TX
• For more information visit the conference website: https://microcaprodeo.com

Benzinga Cannabis Capital Conference

• Presentation date and time: Wednesday, October 23 at 2:20pm CT with management hosting one-on-one meetings the same day
• Location: Palmer House, Chicago, IL
• For more information visit the conference website and use code VAPENVIP for 20% off admission: https://benzingacannabisconference.com/chicago/

For more information on Vapen MJ, please visit our websites at www.VapenMJ.com or www.VapenCBD.com.

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand. Vapen MJ expansion includes partnering with cannabis license holders and hemp farms in multiple states within the US.

Forward Looking Statements
We Seek Safe Harbour.

View original content:http://www.prnewswire.com/news-releases/bob-brilon-vapen-mj-president-and-cfo-to-present-at-upcoming-investor-conferences-300936920.htmlSOURCE Vapen MJ Ventures Corporation